Matches in Nanopublications for { ?s ?p "[In this work, we conduct a case-control study to assess the impact of CYP1A1*2A (CYP1A1 T6235C); NQO1*2 (NQO1 C609T); TPMT*2 (TPMT G238C) and TPMT A719G polymorphisms on the risk of developing ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP616473.RAaprlljVvJx0cU_IusUymN5kx7JNZdQj0BfECfzD4mRY130_assertion description "[In this work, we conduct a case-control study to assess the impact of CYP1A1*2A (CYP1A1 T6235C); NQO1*2 (NQO1 C609T); TPMT*2 (TPMT G238C) and TPMT A719G polymorphisms on the risk of developing ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616473.RAaprlljVvJx0cU_IusUymN5kx7JNZdQj0BfECfzD4mRY130_provenance.
- NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_assertion description "[In this work, we conduct a case-control study to assess the impact of CYP1A1*2A (CYP1A1 T6235C); NQO1*2 (NQO1 C609T); TPMT*2 (TPMT G238C) and TPMT A719G polymorphisms on the risk of developing ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686949.RA6ZVlDtYZ0mNJOWUycE3xMwy9JUqBqmcJjur3ta9IqyY130_provenance.